Loxo Oncology to Announce First Quarter 2018 Financial Results

NEXT STORY
Biomica, Evogene’s Newly Established Subsidiary, Announces Therapeutic Areas of Focus
PREV STORY
AnaptysBio Announces ANB020 and ANB019 Clinical Data Presentations at the 2018 EAACI Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aravive Announces Retrospective Analysis Showing Increased GAS6 Levels Associated with Chemoresistance and Decreased Progression Free Survival in Ovarian Cancer

author_avatar
NASDAQ Market News

ERYTECH verkündet zuvor auf Jahrestagung der American Society of Hematology präsentierte positive Ergebnisse der Phase-II-Studie von Eryaspase bei akuter lymphoblastischer Leukämie

author_avatar
NASDAQ Market News

Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip

author_avatar
NASDAQ Market News